10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ALEC (Alector) Stock Analysis
Buy, Hold or Sell?

Let's analyze Alector together

I guess you are interested in Alector Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Alector’s Financial Insights
  • 📈 Technical Analysis (TA) – Alector’s Price Targets

I'm going to help you getting a better view of Alector Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Alector Inc

I send you an email if I find something interesting about Alector Inc.

1. Quick Overview

1.1. Quick analysis of Alector (30 sec.)










1.2. What can you expect buying and holding a share of Alector? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.9%

What is your share worth?

Current worth
$0.70
Expected worth in 1 year
$-0.08
How sure are you?
28.6%

+ What do you gain per year?

Total Gains per Share
$-0.78
Return On Investment
-26.6%

For what price can you sell your share?

Current Price per Share
$2.95
Expected price per share
$2.155 - $4.18
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Alector (5 min.)




Live pricePrice per Share (EOD)
$2.95
Intrinsic Value Per Share
$-11.37 - $-12.78
Total Value Per Share
$-10.66 - $-12.08

2.2. Growth of Alector (5 min.)




Is Alector growing?

Current yearPrevious yearGrowGrow %
How rich?$71.1m$156.5m-$53.6m-52.2%

How much money is Alector making?

Current yearPrevious yearGrowGrow %
Making money-$28.8m-$40.1m$11.3m39.4%
Net Profit Margin-442.1%-311.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Alector (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#362 / 853

Most Revenue
#216 / 853

Most Profit
#681 / 853

Most Efficient
#571 / 853
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Alector?

Welcome investor! Alector's management wants to use your money to grow the business. In return you get a share of Alector.

First you should know what it really means to hold a share of Alector. And how you can make/lose money.

Speculation

The Price per Share of Alector is $2.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alector.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alector, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.70. Based on the TTM, the Book Value Change Per Share is $-0.20 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alector.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.30-10.2%-0.28-9.7%-0.40-13.5%-0.34-11.7%-0.29-10.0%-0.25-8.3%
Usd Book Value Change Per Share-0.23-7.8%-0.20-6.6%-0.11-3.8%-0.18-6.1%-0.14-4.8%0.020.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.23-7.8%-0.20-6.6%-0.11-3.8%-0.18-6.0%-0.14-4.7%0.020.7%
Usd Price Per Share1.40-2.30-6.26-5.42-9.98-9.07-
Price to Earnings Ratio-1.16--6.95--3.94-4.50-1.77--1.84-
Price-to-Total Gains Ratio-6.05--0.13--12.62--6.42--13.76--21.02-
Price to Book Ratio1.99-2.20-4.13-3.33-4.61-3.89-
Price-to-Total Gains Ratio-6.05--0.13--12.62--6.42--13.76--21.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.95
Number of shares338
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.20-0.14
Usd Total Gains Per Share-0.20-0.14
Gains per Quarter (338 shares)-66.28-47.26
Gains per Year (338 shares)-265.13-189.04
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-265-2751-190-199
20-530-5401-380-388
30-795-8052-569-577
40-1061-10703-759-766
50-1326-13354-949-955
60-1591-16004-1139-1144
70-1856-18655-1329-1333
80-2121-21306-1518-1522
90-2386-23957-1708-1711
100-2651-26607-1898-1900

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%3.031.01.08.6%3.031.01.08.6%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%10.022.03.028.6%10.022.03.028.6%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.034.02.9%1.00.034.02.9%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%10.022.03.028.6%10.022.03.028.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Alector Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.232-0.196-15%-0.113-51%-0.179-23%-0.140-39%0.020-1252%
Book Value Per Share--0.7031.016-31%1.547-55%1.552-55%2.009-65%1.703-59%
Current Ratio--3.7843.454+10%3.542+7%5.046-25%6.011-37%6.126-38%
Debt To Asset Ratio--0.8000.767+4%0.749+7%0.747+7%0.674+19%0.600+33%
Debt To Equity Ratio--4.0083.339+20%3.029+32%3.012+33%2.384+68%1.749+129%
Dividend Per Share----0%-0%0.001-100%0.001-100%0.000-100%
Enterprise Value--163729800.000281005790.000-42%715301310.000-77%637275256.667-74%1141105063.000-86%1385756443.846-88%
Eps---0.302-0.285-6%-0.397+32%-0.345+14%-0.294-3%-0.245-19%
Ev To Ebitda Ratio---1.199-4.441+270%-4.013+235%-11.177+832%-7.946+563%-10.147+746%
Ev To Sales Ratio--5.1986.582-21%13.677-62%11.079-53%27.990-81%48.874-89%
Free Cash Flow Per Share---0.485-0.534+10%-0.538+11%-0.517+7%-0.171-65%-0.127-74%
Free Cash Flow To Equity Per Share---0.483-0.509+5%-0.362-25%-0.448-7%-0.112-77%0.063-866%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%0.971+3%
Intrinsic Value_10Y_max---12.784----------
Intrinsic Value_10Y_min---11.365----------
Intrinsic Value_1Y_max---1.958----------
Intrinsic Value_1Y_min---1.923----------
Intrinsic Value_3Y_max---5.366----------
Intrinsic Value_3Y_min---5.134----------
Intrinsic Value_5Y_max---8.153----------
Intrinsic Value_5Y_min---7.612----------
Market Cap298575400.000+53%141696800.000232281540.000-39%633081060.000-78%548990756.667-74%1010121063.000-86%918267558.286-85%
Net Profit Margin---3.877-4.421+14%-3.111-20%-3.301-15%-4.268+10%-7.249+87%
Operating Margin---4.745-5.050+6%-3.613-24%-3.742-21%-4.550-4%-7.551+59%
Operating Ratio--5.7456.086-6%4.494+28%4.743+21%7.646-25%12.213-53%
Pb Ratio4.195+53%1.9912.195-9%4.128-52%3.330-40%4.614-57%3.887-49%
Pe Ratio-2.445-111%-1.161-6.945+498%-3.938+239%4.501-126%1.769-166%-1.840+59%
Price Per Share2.950+53%1.4002.295-39%6.255-78%5.424-74%9.980-86%9.073-85%
Price To Free Cash Flow Ratio-1.522-111%-0.722-1.104+53%-3.043+321%-2.715+276%-3.950+447%-4.899+578%
Price To Total Gains Ratio-12.741-111%-6.046-0.127-98%-12.618+109%-6.422+6%-13.761+128%-21.017+248%
Quick Ratio--6.7556.343+6%6.403+5%8.950-25%10.187-34%10.436-35%
Return On Assets---0.086-0.068-21%-0.064-25%-0.059-31%-0.056-34%-0.061-29%
Return On Equity---0.429-0.307-28%-0.260-39%-0.245-43%-0.189-56%-0.154-64%
Total Gains Per Share---0.232-0.196-15%-0.113-51%-0.178-23%-0.140-40%0.020-1235%
Usd Book Value--71175000.000102879500.000-31%156546750.000-55%157047666.667-55%203365200.000-65%172396114.286-59%
Usd Book Value Change Per Share---0.232-0.196-15%-0.113-51%-0.179-23%-0.140-39%0.020-1252%
Usd Book Value Per Share--0.7031.016-31%1.547-55%1.552-55%2.009-65%1.703-59%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%0.000-100%
Usd Enterprise Value--163729800.000281005790.000-42%715301310.000-77%637275256.667-74%1141105063.000-86%1385756443.846-88%
Usd Eps---0.302-0.285-6%-0.397+32%-0.345+14%-0.294-3%-0.245-19%
Usd Free Cash Flow---49056000.000-54001500.000+10%-54440500.000+11%-52351750.000+7%-17317600.000-65%-12458142.857-75%
Usd Free Cash Flow Per Share---0.485-0.534+10%-0.538+11%-0.517+7%-0.171-65%-0.127-74%
Usd Free Cash Flow To Equity Per Share---0.483-0.509+5%-0.362-25%-0.448-7%-0.112-77%0.063-866%
Usd Market Cap298575400.000+53%141696800.000232281540.000-39%633081060.000-78%548990756.667-74%1010121063.000-86%918267558.286-85%
Usd Price Per Share2.950+53%1.4002.295-39%6.255-78%5.424-74%9.980-86%9.073-85%
Usd Profit---30524000.000-28822250.000-6%-40166000.000+32%-34917583.333+14%-29747850.000-3%-24869000.000-19%
Usd Revenue--7874000.00020282500.000-61%13818750.000-43%19871666.667-60%28031350.000-72%17829000.000-56%
Usd Total Gains Per Share---0.232-0.196-15%-0.113-51%-0.178-23%-0.140-40%0.020-1235%
 EOD+5 -3MRQTTM+13 -24YOY+12 -253Y+11 -285Y+7 -3210Y+8 -32

3.3 Fundamental Score

Let's check the fundamental score of Alector Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.445
Price to Book Ratio (EOD)Between0-14.195
Net Profit Margin (MRQ)Greater than0-3.877
Operating Margin (MRQ)Greater than0-4.745
Quick Ratio (MRQ)Greater than16.755
Current Ratio (MRQ)Greater than13.784
Debt to Asset Ratio (MRQ)Less than10.800
Debt to Equity Ratio (MRQ)Less than14.008
Return on Equity (MRQ)Greater than0.15-0.429
Return on Assets (MRQ)Greater than0.05-0.086
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Alector Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.757
Ma 20Greater thanMa 502.637
Ma 50Greater thanMa 1002.118
Ma 100Greater thanMa 2001.733
OpenGreater thanClose2.770
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Alector Inc

Alector, Inc., a late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases. The company's products under development include Latozinemab (AL001), an investigational human recombinant monoclonal antibody designed to elevate progranulin (PGRN), a protein encoded by the granulin (GRN) gene that regulates lysosomal function, neuronal survival, and inflammation in the brain. Its lead PGRN-elevating candidate is being developed for the potential treatment of frontotemporal dementia with a granulin gene mutation (FTD-GRN) which is caused by heterozygous loss-of-function (LOF) mutations in the GRN gene and results in PGRN haploinsufficiency and is in Phase 3 clinical trial. It also develops AL101/GSK4527226 that is in Phase 2 clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. In addition, the company's preclinical and research pipeline products include ADP037-ABC, a proprietary anti-amyloid beta (Aß) antibody paired with proprietary ABC for the treatment of AD; ADP050-ABC, a GCase replacement therapy paired with proprietary ABC for GBA gene mutation carriers with Parkinson's disease and Lewy body dementia; ADP056, a Reelin modulator designed to block tau pathology and promote synaptic function in AD; and ADP063-ABC and ADP064-ABC that are therapeutic candidates paired with proprietary ABC that target tau pathology in AD through distinct approaches. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including latozinemab and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2025-08-23 09:49:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Alector earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Alector to the Biotechnology industry mean.
  • A Net Profit Margin of -387.7% means that $-3.88 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alector Inc:

  • The MRQ is -387.7%. The company is making a huge loss. -2
  • The TTM is -442.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-387.7%TTM-442.1%+54.4%
TTM-442.1%YOY-311.1%-130.9%
TTM-442.1%5Y-426.8%-15.3%
5Y-426.8%10Y-724.9%+298.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-387.7%-85.5%-302.2%
TTM-442.1%-171.0%-271.1%
YOY-311.1%-210.0%-101.1%
3Y-330.1%-289.9%-40.2%
5Y-426.8%-381.1%-45.7%
10Y-724.9%-520.3%-204.6%
4.3.1.2. Return on Assets

Shows how efficient Alector is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alector to the Biotechnology industry mean.
  • -8.6% Return on Assets means that Alector generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alector Inc:

  • The MRQ is -8.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.6%TTM-6.8%-1.8%
TTM-6.8%YOY-6.4%-0.3%
TTM-6.8%5Y-5.6%-1.1%
5Y-5.6%10Y-6.1%+0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.6%-11.9%+3.3%
TTM-6.8%-11.9%+5.1%
YOY-6.4%-11.2%+4.8%
3Y-5.9%-12.0%+6.1%
5Y-5.6%-11.7%+6.1%
10Y-6.1%-13.8%+7.7%
4.3.1.3. Return on Equity

Shows how efficient Alector is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alector to the Biotechnology industry mean.
  • -42.9% Return on Equity means Alector generated $-0.43 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alector Inc:

  • The MRQ is -42.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -30.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-42.9%TTM-30.7%-12.2%
TTM-30.7%YOY-26.0%-4.7%
TTM-30.7%5Y-18.9%-11.8%
5Y-18.9%10Y-15.4%-3.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.9%-14.2%-28.7%
TTM-30.7%-15.2%-15.5%
YOY-26.0%-15.3%-10.7%
3Y-24.5%-16.9%-7.6%
5Y-18.9%-17.5%-1.4%
10Y-15.4%-19.6%+4.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Alector Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Alector is operating .

  • Measures how much profit Alector makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alector to the Biotechnology industry mean.
  • An Operating Margin of -474.5% means the company generated $-4.74  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alector Inc:

  • The MRQ is -474.5%. The company is operating very inefficient. -2
  • The TTM is -505.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-474.5%TTM-505.0%+30.5%
TTM-505.0%YOY-361.3%-143.7%
TTM-505.0%5Y-455.0%-50.0%
5Y-455.0%10Y-755.1%+300.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-474.5%-154.1%-320.4%
TTM-505.0%-280.2%-224.8%
YOY-361.3%-268.7%-92.6%
3Y-374.2%-281.5%-92.7%
5Y-455.0%-350.8%-104.2%
10Y-755.1%-530.7%-224.4%
4.3.2.2. Operating Ratio

Measures how efficient Alector is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 5.74 means that the operating costs are $5.74 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Alector Inc:

  • The MRQ is 5.745. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.086. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.745TTM6.086-0.341
TTM6.086YOY4.494+1.592
TTM6.0865Y7.646-1.561
5Y7.64610Y12.213-4.566
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7451.952+3.793
TTM6.0862.974+3.112
YOY4.4943.047+1.447
3Y4.7433.835+0.908
5Y7.6464.924+2.722
10Y12.2136.864+5.349
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Alector Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Alector is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.78 means the company has $3.78 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Alector Inc:

  • The MRQ is 3.784. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.454. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.784TTM3.454+0.330
TTM3.454YOY3.542-0.089
TTM3.4545Y6.011-2.558
5Y6.01110Y6.126-0.115
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7843.480+0.304
TTM3.4543.790-0.336
YOY3.5424.104-0.562
3Y5.0464.609+0.437
5Y6.0115.764+0.247
10Y6.1266.154-0.028
4.4.3.2. Quick Ratio

Measures if Alector is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alector to the Biotechnology industry mean.
  • A Quick Ratio of 6.75 means the company can pay off $6.75 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alector Inc:

  • The MRQ is 6.755. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.343. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.755TTM6.343+0.412
TTM6.343YOY6.403-0.060
TTM6.3435Y10.187-3.845
5Y10.18710Y10.436-0.249
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7552.938+3.817
TTM6.3433.291+3.052
YOY6.4033.928+2.475
3Y8.9504.393+4.557
5Y10.1875.837+4.350
10Y10.4366.549+3.887
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Alector Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Alector assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alector to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.80 means that Alector assets are financed with 80.0% credit (debt) and the remaining percentage (100% - 80.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alector Inc:

  • The MRQ is 0.800. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.767. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.800TTM0.767+0.033
TTM0.767YOY0.749+0.018
TTM0.7675Y0.674+0.092
5Y0.67410Y0.600+0.075
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8000.339+0.461
TTM0.7670.359+0.408
YOY0.7490.334+0.415
3Y0.7470.341+0.406
5Y0.6740.349+0.325
10Y0.6000.379+0.221
4.5.4.2. Debt to Equity Ratio

Measures if Alector is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alector to the Biotechnology industry mean.
  • A Debt to Equity ratio of 400.8% means that company has $4.01 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alector Inc:

  • The MRQ is 4.008. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.339. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.008TTM3.339+0.669
TTM3.339YOY3.029+0.310
TTM3.3395Y2.384+0.955
5Y2.38410Y1.749+0.635
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0080.391+3.617
TTM3.3390.436+2.903
YOY3.0290.436+2.593
3Y3.0120.461+2.551
5Y2.3840.461+1.923
10Y1.7490.514+1.235
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Alector generates.

  • Above 15 is considered overpriced but always compare Alector to the Biotechnology industry mean.
  • A PE ratio of -1.16 means the investor is paying $-1.16 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alector Inc:

  • The EOD is -2.445. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.161. Based on the earnings, the company is expensive. -2
  • The TTM is -6.945. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.445MRQ-1.161-1.285
MRQ-1.161TTM-6.945+5.785
TTM-6.945YOY-3.938-3.007
TTM-6.9455Y1.769-8.714
5Y1.76910Y-1.840+3.609
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.445-2.539+0.094
MRQ-1.161-2.361+1.200
TTM-6.945-2.657-4.288
YOY-3.938-3.749-0.189
3Y4.501-3.883+8.384
5Y1.769-6.353+8.122
10Y-1.840-7.102+5.262
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alector Inc:

  • The EOD is -1.522. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.722. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.104. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.522MRQ-0.722-0.799
MRQ-0.722TTM-1.104+0.382
TTM-1.104YOY-3.043+1.939
TTM-1.1045Y-3.950+2.846
5Y-3.95010Y-4.899+0.950
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.522-3.411+1.889
MRQ-0.722-2.951+2.229
TTM-1.104-3.614+2.510
YOY-3.043-4.421+1.378
3Y-2.715-5.258+2.543
5Y-3.950-8.587+4.637
10Y-4.899-9.639+4.740
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Alector is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.99 means the investor is paying $1.99 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Alector Inc:

  • The EOD is 4.195. Based on the equity, the company is fair priced.
  • The MRQ is 1.991. Based on the equity, the company is underpriced. +1
  • The TTM is 2.195. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD4.195MRQ1.991+2.204
MRQ1.991TTM2.195-0.204
TTM2.195YOY4.128-1.933
TTM2.1955Y4.614-2.418
5Y4.61410Y3.887+0.727
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.1952.206+1.989
MRQ1.9912.027-0.036
TTM2.1952.194+0.001
YOY4.1282.425+1.703
3Y3.3302.571+0.759
5Y4.6143.805+0.809
10Y3.8874.462-0.575
4.6.2. Total Gains per Share

2.4. Latest News of Alector Inc

Does Alector Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Alector Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-17
21:20
Notable Wednesday Option Activity: BAC, WHR, ALECRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Alector Inc.

4.8.1. Institutions holding Alector Inc

Institutions are holding 77.452% of the shares of Alector Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31FMR Inc14.21790.001114390239-299626-2.0397
2025-03-31RA Capital Management, LLC9.57910.1992969522800
2025-03-31BlackRock Inc8.18050.00028279702-857045-9.3802
2025-06-30Vanguard Group Inc5.9160.00015987704-65337-1.0794
2025-06-30T. Rowe Price Associates, Inc.4.81690.000848752644198951620.8591
2025-03-31Merck & Co Inc3.50322.6547354571900
2025-06-30Eversept Partners, LLC1.96230.255719860721368654221.6738
2025-03-31Geode Capital Management, LLC1.93860.00021962098478482.4996
2025-03-31State Street Corp1.62060.00011640262-209033-11.3034
2025-03-31JPMorgan Chase & Co1.46830.00011486149-156421-9.5229
2025-03-31Acadian Asset Management LLC1.42340.005144066113844222461.6761
2025-03-31Jacobs Levy Equity Management, Inc.1.31810.0065133403227434125.8888
2025-06-30Euclidean Capital LLC1.29220.5989130785800
2025-03-31Deutsche Bank AG1.08840.00051101547-4740-0.4285
2025-03-31Deerfield Management Co1.04260.02561055192-11770-1.1031
2025-03-31Renaissance Technologies Corp1.02150.0019103385511811712.8986
2025-03-315AM Venture Management, LLC0.98390.463399584100
2025-03-31Ikarian Capital, LLC0.93860.14495000000
2025-03-31Dafna Capital Management LLC0.9020.318491292800
2025-03-31Sio Capital Management, LLC0.82710.306683715922153135.9846
Total 64.04124.982964817510+6009892+9.3%

4.9.2. Funds holding Alector Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30Fidelity Growth Compy Commingled Pl S5.3090.00815373356750441.4164
2025-06-30T. Rowe Price Health Sciences3.74730.0473792774-142802-3.6285
2025-06-30Fidelity Growth Company Fund3.68210.00763726748513001.3957
2025-06-30Fidelity Select Biotechnology3.54750.1342359055157629819.1191
2025-06-30Vanguard Total Stock Mkt Idx Inv2.44140.0002247099100
2025-07-31iShares Russell 2000 ETF1.83910.00461861430-35385-1.8655
2025-06-30Fidelity Growth Company K61.24020.0086125521397560.7833
2025-06-30Vanguard Institutional Extnd Mkt Idx Tr1.14840.0014116229700
2025-06-30Fidelity Series Growth Company0.98750.0073999455-200-0.02
2025-05-31Fidelity Small Cap Index0.83190.004584196974050.8873
2025-06-30BlackRock Advantage Small Cap Core Instl0.66770.02367574500
2025-07-31iShares Russell 2000 Value ETF0.6240.00876315544690.0743
2025-06-30Vanguard Strategic Small-Cap Equity Inv0.62110.049162862700
2025-07-31State St Russell Sm/Mid Cp® Indx SL Cl I0.51570.001852197700
2025-06-30Vanguard VIF Small Co Gr0.48940.04849529900
2025-07-31iShares Biotechnology ETF0.45160.012545707339060.8619
2025-06-30Fidelity Extended Market Index0.44370.0016449029-1172-0.2603
2025-06-30Vanguard Explorer Inv0.41130.002941628700
2025-06-30Vanguard Russell 2000 ETF0.3770.0041381541-22733-5.6232
2025-07-31Schwab US Small-Cap ETF™0.37380.0034378328-189-0.0499
Total 29.74970.378630110244+521697+1.7%

5.3. Insider Transactions

Insiders are holding 10.483% of the shares of Alector Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-20Kristine YaffeSELL10001.44
2024-12-02Arnon RosenthalSELL521722.52
2024-12-02Marc GrassoSELL164892.52
2024-12-02Sara Kenkare-mitraSELL265002.52
2024-09-03Arnon RosenthalSELL264994.88
2024-09-03Marc GrassoSELL72974.88
2024-09-03Sara Kenkare-mitraSELL139264.88
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets356,422
Total Liabilities285,247
Total Stockholder Equity71,175
 As reported
Total Liabilities 285,247
Total Stockholder Equity+ 71,175
Total Assets = 356,422

Assets

Total Assets356,422
Total Current Assets319,178
Long-term Assets37,244
Total Current Assets
Cash And Cash Equivalents 44,771
Short-term Investments 262,509
Other Current Assets 11,898
Total Current Assets  (as reported)319,178
Total Current Assets  (calculated)319,178
+/-0
Long-term Assets
Property Plant Equipment 30,904
Long-term Assets Other 4,494
Long-term Assets  (as reported)37,244
Long-term Assets  (calculated)35,398
+/- 1,846

Liabilities & Shareholders' Equity

Total Current Liabilities84,354
Long-term Liabilities200,893
Total Stockholder Equity71,175
Total Current Liabilities
Short-term Debt 8,904
Accounts payable 2,217
Other Current Liabilities 59,831
Total Current Liabilities  (as reported)84,354
Total Current Liabilities  (calculated)70,952
+/- 13,402
Long-term Liabilities
Long term Debt 9,536
Capital Lease Obligations 29,947
Long-term Liabilities Other 1,444
Long-term Liabilities  (as reported)200,893
Long-term Liabilities  (calculated)40,927
+/- 159,966
Total Stockholder Equity
Common Stock9
Retained Earnings -900,122
Accumulated Other Comprehensive Income 96
Other Stockholders Equity 971,192
Total Stockholder Equity (as reported)71,175
Total Stockholder Equity (calculated)71,175
+/-0
Other
Capital Stock9
Cash and Short Term Investments 307,280
Common Stock Shares Outstanding 100,372
Current Deferred Revenue13,402
Liabilities and Stockholders Equity 356,422
Net Debt -5,288
Net Invested Capital 80,711
Net Working Capital 234,824
Property Plant and Equipment Gross 30,904
Short Long Term Debt Total 39,483



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
54,111
0
0
0
236,060
274,883
274,883
318,699
308,359
496,044
477,251
449,730
421,913
618,928
572,030
531,588
488,251
440,364
397,113
854,226
814,658
954,457
889,672
837,038
787,648
748,342
708,737
672,395
621,827
635,494
570,729
516,023
468,303
408,303
356,422
356,422408,303468,303516,023570,729635,494621,827672,395708,737748,342787,648837,038889,672954,457814,658854,226397,113440,364488,251531,588572,030618,928421,913449,730477,251496,044308,359318,699274,883274,883236,06000054,111
   > Total Current Assets 
0
0
0
0
232,974
32,451
270,020
312,617
293,176
442,114
414,597
385,483
357,437
556,204
510,088
470,012
421,511
374,737
329,330
788,019
749,713
890,926
827,021
774,963
726,435
686,002
647,992
613,147
565,807
581,390
519,701
469,364
424,817
366,650
319,178
319,178366,650424,817469,364519,701581,390565,807613,147647,992686,002726,435774,963827,021890,926749,713788,019329,330374,737421,511470,012510,088556,204357,437385,483414,597442,114293,176312,617270,02032,451232,9740000
       Cash And Cash Equivalents 
50,838
0
0
0
32,451
-32,451
48,910
41,939
65,470
60,954
69,208
86,974
89,641
160,917
92,501
84,979
49,969
110,703
125,713
516,532
329,152
454,620
172,265
184,231
154,323
195,555
131,540
101,964
74,555
72,552
47,545
37,159
33,021
37,973
44,771
44,77137,97333,02137,15947,54572,55274,555101,964131,540195,555154,323184,231172,265454,620329,152516,532125,713110,70349,96984,97992,501160,91789,64186,97469,20860,95465,47041,93948,910-32,45132,45100050,838
       Short-term Investments 
0
0
0
0
0
64,902
219,189
266,755
224,938
375,641
341,725
294,472
263,432
387,618
411,139
376,735
363,339
252,041
193,857
261,318
406,099
413,951
636,590
574,075
558,528
473,774
498,508
486,897
474,306
489,531
455,789
420,043
380,376
316,578
262,509
262,509316,578380,376420,043455,789489,531474,306486,897498,508473,774558,528574,075636,590413,951406,099261,318193,857252,041363,339376,735411,139387,618263,432294,472341,725375,641224,938266,755219,18964,90200000
       Net Receivables 
0
0
0
0
200,238
0
0
0
0
0
0
0
0
1,500
1,400
1,200
0
0
0
1,584
7,391
12,819
8,816
6,491
2,587
4,699
7,825
10,465
0
0
0
0
0
0
0
000000010,4657,8254,6992,5876,4918,81612,8197,3911,5840001,2001,4001,50000000000200,2380000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
3,086
-32,451
4,863
6,082
15,183
53,930
62,654
64,247
64,476
62,724
61,942
61,576
66,740
65,627
67,783
66,207
64,945
63,531
62,651
62,075
61,213
62,340
60,745
59,248
56,020
54,104
51,028
46,659
43,486
41,653
37,244
37,24441,65343,48646,65951,02854,10456,02059,24860,74562,34061,21362,07562,65163,53164,94566,20767,78365,62766,74061,57661,94262,72464,47664,24762,65453,93015,1836,0824,863-32,4513,0860000
       Property Plant Equipment 
2,536
0
0
0
2,834
3,246
3,246
3,555
10,937
52,398
61,072
62,626
62,328
60,849
59,384
57,887
62,651
61,563
60,318
59,019
57,899
56,127
55,260
54,819
53,332
52,064
50,591
49,154
47,056
45,156
43,367
39,025
37,096
35,289
30,904
30,90435,28937,09639,02543,36745,15647,05649,15450,59152,06453,33254,81955,26056,12757,89959,01960,31861,56362,65157,88759,38460,84962,32862,62661,07252,39810,9373,5553,2463,2462,8340002,536
       Long-term Assets Other 
0
0
0
0
252
-32,451
1,617
2,527
4,246
1,532
1,582
1,621
2,148
1,875
2,558
3,689
4,089
2,592
5,993
5,716
5,574
5,932
5,919
5,784
6,409
8,804
8,605
8,548
7,418
7,402
6,115
6,088
6,390
6,364
4,494
4,4946,3646,3906,0886,1157,4027,4188,5488,6058,8046,4095,7845,9195,9325,5745,7165,9932,5924,0893,6892,5581,8752,1481,6211,5821,5324,2462,5271,617-32,4512520000
> Total Liabilities 
1,533
0
0
0
288,093
196,712
36,889
401,482
405,757
229,858
231,535
231,143
227,170
227,194
216,699
221,397
220,721
212,535
212,598
518,336
513,934
686,920
601,156
583,934
573,206
565,327
512,431
509,840
487,669
456,587
420,162
397,090
341,503
313,693
285,247
285,247313,693341,503397,090420,162456,587487,669509,840512,431565,327573,206583,934601,156686,920513,934518,336212,598212,535220,721221,397216,699227,194227,170231,143231,535229,858405,757401,48236,889196,712288,0930001,533
   > Total Current Liabilities 
1,510
0
0
0
27,403
36,889
36,889
41,029
13,043
55,834
67,102
58,718
31,805
71,775
65,856
71,087
44,202
64,062
74,393
132,815
48,218
142,878
149,409
160,889
45,578
99,300
132,270
155,402
177,948
164,917
147,682
142,525
125,059
109,773
84,354
84,354109,773125,059142,525147,682164,917177,948155,402132,27099,30045,578160,889149,409142,87848,218132,81574,39364,06244,20271,08765,85671,77531,80558,71867,10255,83413,04341,02936,88936,88927,4030001,510
       Short-term Debt 
0
0
0
0
0
0
0
0
34,905
8,770
10,266
11,950
6,565
13,246
13,358
13,472
7,512
15,396
15,520
15,574
7,795
15,710
15,844
15,980
8,059
16,260
16,398
16,780
8,462
17,070
8,607
8,680
8,754
8,830
8,904
8,9048,8308,7548,6808,60717,0708,46216,78016,39816,2608,05915,98015,84415,7107,79515,57415,52015,3967,51213,47213,35813,2466,56511,95010,2668,77034,90500000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
4,385
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000004,385000000000
       Accounts payable 
1,152
0
0
0
1,140
105
105
331
126
1,200
540
258
278
4,039
4,760
1,370
3,004
5,310
11,942
2,341
4,749
6,752
4,646
4,546
4,189
3,126
4,667
4,679
3,775
4,586
4,375
5,017
2,215
2,326
2,217
2,2172,3262,2155,0174,3754,5863,7754,6794,6673,1264,1894,5464,6466,7524,7492,34111,9425,3103,0041,3704,7604,0392782585401,2001263311051051,1400001,152
       Other Current Liabilities 
358
0
0
0
7,285
30,552
36,784
40,698
12,917
7,338
15,425
16,983
24,962
22,401
8,320
29,649
33,686
20,656
21,514
20,217
36,208
24,805
21,925
20,679
33,330
18,141
42,655
53,382
82,736
69,909
70,739
73,401
90,427
76,767
59,831
59,83176,76790,42773,40170,73969,90982,73653,38242,65518,14133,33020,67921,92524,80536,20820,21721,51420,65633,68629,6498,32022,40124,96216,98315,4257,33812,91740,69836,78430,5527,285000358
   > Long-term Liabilities 
0
0
0
0
260,690
0
0
360,453
392,714
174,024
164,433
172,425
195,365
155,419
150,843
150,310
176,519
148,473
138,205
385,521
465,716
544,042
451,747
423,045
527,628
466,027
380,161
354,438
309,721
291,670
272,480
254,565
216,444
203,920
200,893
200,893203,920216,444254,565272,480291,670309,721354,438380,161466,027527,628423,045451,747544,042465,716385,521138,205148,473176,519150,310150,843155,419195,365172,425164,433174,024392,714360,45300260,6900000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
-34,905
39,054
37,664
36,166
41,471
34,162
33,350
32,521
43,744
35,124
34,079
33,047
39,806
30,896
29,693
28,465
35,268
25,920
24,546
23,453
30,456
20,487
27,506
25,959
24,376
22,754
21,043
21,04322,75424,37625,95927,50620,48730,45623,45324,54625,92035,26828,46529,69330,89639,80633,04734,07935,12443,74432,52133,35034,16241,47136,16637,66439,054-34,90500000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
96
409
409
493
493
493
150,310
152,633
148,473
158
385,521
374,379
544,042
451,747
423,045
759
466,027
898
898
1,373
1,373
1,234
1,234
1,234
1,394
1,444
1,4441,3941,2341,2341,2341,3731,373898898466,027759423,045451,747544,042374,379385,521158148,473152,633150,31049349349340940996000000000
       Deferred Long Term Liability 
0
0
0
0
0
100
100
1,000
2,700
0
0
0
600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000006000002,7001,00010010000000
> Total Stockholder Equity
52,578
0
0
0
-52,033
25,452
78,171
-82,783
-97,398
266,186
245,716
218,587
194,743
391,734
355,331
310,191
267,530
227,829
184,515
335,890
300,724
267,537
288,516
253,104
214,442
183,015
196,306
162,555
134,158
178,907
150,567
118,933
126,800
94,610
71,175
71,17594,610126,800118,933150,567178,907134,158162,555196,306183,015214,442253,104288,516267,537300,724335,890184,515227,829267,530310,191355,331391,734194,743218,587245,716266,186-97,398-82,78378,17125,452-52,03300052,578
   Common Stock
0
0
0
0
1
1
1
1
1
7
7
7
7
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
9
9
9
9
9
9
99999988888888888888887777111110000
   Retained Earnings Total Equity000000000-625,5440-527,259-481,111-490,994-446,377-390,769-517,366-462,219-410,048-357,869-305,165-259,839-219,820-189,293-157,555-132,995000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-980
-52,033
-92
-140
-42
108
441
226
142
2,782
1,846
1,094
614
410
203
-41
-943
-3,935
-6,224
-6,742
-4,575
-2,199
-1,386
-721
184
-403
-620
931
261
191
96
96191261931-620-403184-721-1,386-2,199-4,575-6,742-6,224-3,935-943-412034106141,0941,8462,782142226441108-42-140-92-52,033-9800000
   Capital Surplus 
0
0
0
0
0
0
0
0
17,078
399,066
402,823
407,647
414,414
648,783
658,642
666,958
676,956
689,630
701,670
726,692
748,036
762,458
775,843
787,097
0
810,750
0
0
0
0
0
0
0
0
0
000000000810,7500787,097775,843762,458748,036726,692701,670689,630676,956666,958658,642648,783414,414407,647402,823399,06617,07800000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
11,133
-92
12,438
-210,170
17,078
399,066
402,823
407,647
414,414
648,783
658,642
666,958
676,956
689,630
701,670
726,692
748,036
762,458
775,843
787,097
798,696
810,750
821,853
831,912
844,044
925,458
936,011
945,046
955,657
964,008
971,192
971,192964,008955,657945,046936,011925,458844,044831,912821,853810,750798,696787,097775,843762,458748,036726,692701,670689,630676,956666,958658,642648,783414,414407,647402,823399,06617,078-210,17012,438-9211,1330000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue100,558
Cost of Revenue-8,841
Gross Profit91,71791,717
 
Operating Income (+$)
Gross Profit91,717
Operating Expense-59,615
Operating Income-144,99732,102
 
Operating Expense (+$)
Research Development185,940
Selling General Administrative59,615
Selling And Marketing Expenses0
Operating Expense59,615245,555
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-144,997
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-118,921-171,073
EBIT - interestExpense = -144,997
-118,921
-119,049
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-144,997-118,921
Earnings Before Interest and Taxes (EBITDA)-136,156
 
After tax Income (+$)
Income Before Tax-118,921
Tax Provision-128
Net Income From Continuing Ops-119,049-119,049
Net Income-119,049
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses245,555
Total Other Income/Expenses Net26,0760
 

Technical Analysis of Alector
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alector. The general trend of Alector is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alector's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Alector Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alector Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 3.07 < 4.11 < 4.18.

The bearish price targets are: 2.56 > 2.3 > 2.155.

Know someone who trades $ALEC? Share this with them.👇

Alector Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alector Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alector Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alector Inc. The current macd is 0.23169053.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alector price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Alector. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Alector price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Alector Inc Daily Moving Average Convergence/Divergence (MACD) ChartAlector Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alector Inc. The current adx is 47.44.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Alector shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Alector Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alector Inc. The current sar is 2.71.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Alector Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alector Inc. The current rsi is 62.76. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Alector Inc Daily Relative Strength Index (RSI) ChartAlector Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alector Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Alector price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Alector Inc Daily Stochastic Oscillator ChartAlector Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alector Inc. The current cci is 92.39.

Alector Inc Daily Commodity Channel Index (CCI) ChartAlector Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alector Inc. The current cmo is 24.36.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Alector Inc Daily Chande Momentum Oscillator (CMO) ChartAlector Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alector Inc. The current willr is -26.13636364.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Alector is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Alector Inc Daily Williams %R ChartAlector Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Alector Inc.

Alector Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alector Inc. The current atr is 0.22508495.

Alector Inc Daily Average True Range (ATR) ChartAlector Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alector Inc. The current obv is 29,243,891.

Alector Inc Daily On-Balance Volume (OBV) ChartAlector Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alector Inc. The current mfi is 49.66.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Alector Inc Daily Money Flow Index (MFI) ChartAlector Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alector Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-09-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-09-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Alector Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alector Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.757
Ma 20Greater thanMa 502.637
Ma 50Greater thanMa 1002.118
Ma 100Greater thanMa 2001.733
OpenGreater thanClose2.770
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Alector with someone you think should read this too:
  • Are you bullish or bearish on Alector? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alector? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alector Inc

I send you an email if I find something interesting about Alector Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Alector Inc.

Receive notifications about Alector Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.